Personalis (PSNL) CFO trades 4,982 shares under Rule 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Personalis, Inc. executive Aaron Tachibana, the company’s CFO and COO, reported an exercise-and-sell transaction in company stock. He exercised stock options covering 4,982 shares of common stock at an exercise price of $5.32 per share, then sold 4,982 shares of common stock in an open-market sale at $14.00 per share. According to the disclosure, these trades were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on August 7, 2025, which means the timing was set in advance. After the transactions, Tachibana directly held 198,833 shares of Personalis common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 4,982 shares ($69,748)
Net Sell
3 txns
Insider
Tachibana Aaron
Role
CFO AND COO
Sold
4,982 shs ($70K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 4,982 | $0.00 | -- |
| Exercise | Common Stock | 4,982 | $5.32 | $27K |
| Sale | Common Stock | 4,982 | $14.00 | $70K |
Holdings After Transaction:
Stock Option (right to buy) — 2,489 shares (Direct, null);
Common Stock — 203,815 shares (Direct, null)
Footnotes (1)
- The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025. The shares subject to the option are fully vested and exercisable.
Key Figures
Shares sold: 4,982 shares
Sale price: $14.00 per share
Options exercised: 4,982 shares
+3 more
6 metrics
Shares sold
4,982 shares
Open-market sale of common stock
Sale price
$14.00 per share
Price for 4,982 common shares sold
Options exercised
4,982 shares
Common stock acquired via option exercise
Exercise price
$5.32 per share
Stock option exercise price
Shares held after
198,833 shares
Direct common stock ownership post-transaction
Option expiration
August 15, 2032
Expiration date of the stock option grant
Key Terms
Rule 10b5-1 trading plan, Stock Option (right to buy), open-market sale, Exercise or conversion of derivative security
4 terms
Rule 10b5-1 trading plan regulatory
"The sales and option exercise ... were effected pursuant to a Rule 10b5-1 trading plan..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
FAQ
What insider transaction did Personalis (PSNL) report for Aaron Tachibana?
Personalis CFO and COO Aaron Tachibana exercised stock options for 4,982 shares and sold 4,982 common shares. The filing shows this as an exercise-and-sell sequence, with the option exercise priced at $5.32 and the sale at $14.00 per share.
Was Aaron Tachibana’s Personalis (PSNL) stock sale under a Rule 10b5-1 plan?
Yes. The footnotes state that the sales and option exercise were effected under a Rule 10b5-1 trading plan adopted on August 7, 2025. Such pre-arranged plans schedule trades in advance, making the timing more routine and less discretionary.
What type of securities did Aaron Tachibana exercise in the Personalis (PSNL) Form 4?
He exercised a stock option described as a “Stock Option (right to buy)” covering 4,982 shares of Personalis common stock. The option carried a $5.32 exercise price and remained outstanding in reduced amount after exercise, with an expiration date in August 2032.